Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis

    August 2013 in “ Case reports in dermatology
    Hassan Riad, Haya Al Mannai, Khalid Mansour, Khalifa Al Qaatri, Sharifa Al Dosari, Amina Al Obaidaly, Emad Sultan
    Image of study
    TLDR A patient with total hair loss developed vitiligo after using a treatment called DCP.
    This document reported a case where a patient with alopecia universalis developed vitiligo after treatment with diphenylcyclopropenone (DCP). Both alopecia areata and vitiligo are autoimmune diseases that often co-occur and share many susceptibility genes. The use of DCP, a common treatment for alopecia areata, was noted to potentially induce vitiligo, suggesting a link through follicular melanocyte destruction.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    6 / 6 results